Show simple item record

dc.contributor.authorMarder, Shira
dc.date.accessioned2018-11-12T20:43:37Z
dc.date.available2018-11-12T20:43:37Z
dc.date.issued2014-04
dc.identifier.urihttps://hdl.handle.net/20.500.12202/4218
dc.identifier.urihttps://yulib002.mc.yu.edu/login?url=https://repository.yu.edu/handle/20.500.12202/4218
dc.descriptionThe file is restricted for YU community access only.
dc.description.abstractMontefiore Medical Center provides medical care through 20 school-based health centers, serving 56 New York City public schools in the Bronx. Amongst these are 13 school campuses participating in the Point of Care Testing (POCT) Rapid-HIV program. This analysis determines the cost, benefit and utility of the POCT OraQuick Advance HIV-1/2 Rapid Antibody Testing (HIV-R) as compared to standard in lab testing (HIV-IL) in the New York City public school system. Pre-analytic, analytic and post-analytic variables were considered. The cost effectiveness of HIV-R as compared to HIV-IL was found to be dependent upon the personnel performing and reviewing the test, volume of tests/month, and amount of time spent reviewing results. When testing volume exceeded an average 20 tests/month, HIV-R was more cost effective. Students received their HIV-R results within 27.3 min, but could wait several days to receive their HIV-IL results due to scheduling issues. According to the EMR Database, 69.9% of students receiving HIV-R testing came in for reproductive health reasons or HIV/STI screening. Additionally, 66% of those tested were female and 34% male. Providers reported a dramatic increase in consent rates when switching to HIV-R, with many students consenting when learning of the test’s non-invasive nature.en_US
dc.description.sponsorshipS. Daniel Abraham Honors Programen_US
dc.language.isoen_USen_US
dc.publisherStern College for Womenen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectPoint-of-care testing --New York (State) --New York.en_US
dc.subjectAIDS (Disease) --Prevention --Cost effectiveness.en_US
dc.subjectAIDS (Disease) --Study and teaching --New York (State) --New York.en_US
dc.subjectInformed consent (Medical law) --New York (State) --New York.en_US
dc.subjectHIV antibodies --New York (State) --New York --Testing.en_US
dc.subjectPublic schools --New York (State) --New York.en_US
dc.titleIs Point of Care Rapid-HIV Testing in New York City School-Based Health Centers Worthwhile? An Analysis of Cost, Benefit and Utilityen_US
dc.typeThesisen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States